Primary care physicians’ role perception and self-reported performance in glaucoma care: a survey study by Albina Rotshtein et al.
Rotshtein et al. BMC Res Notes  (2015) 8:776 
DOI 10.1186/s13104-015-1770-z
RESEARCH ARTICLE
Primary care physicians’ role perception 
and self-reported performance in glaucoma 
care: a survey study
Albina Rotshtein1,2, Khaled Karkabi1,2, Orna Geyer4 and Orit Cohen Castel2,3*
Abstract 
Background: Glaucoma is a leading cause of blindness. The participation of primary care physicians (PCPs) in glau-
coma care may improve health outcomes for glaucoma patients.
Objectives: To investigate PCPs’ attitudes towards their role in glaucoma care, perceived barriers, and self-reported 
performance in glaucoma management.
Methods: PCPs working in the Haifa and Western Galilee District of Clalit Health Services, Israel’s largest Health Main-
tenance Organization (HMO) were asked to complete a self-administered structured questionnaire. Physicians were 
asked to rate their agreement with statements describing the PCP’s role in glaucoma care, and to state how often 
they behave accordingly in their practice. In addition, physicians were asked to rate the extent that factors such as 
time constraints and knowledge gaps impede their performance in glaucoma care.
Results: Eighty-two physicians completed the questionnaire. The majority thought that PCPs have a major role in 
early detection of glaucoma (99 %), discussing the importance of adherence to treatment (93 %), and encouraging 
patients to make regular visits to their ophthalmologist (99 %). However, only 30 % reported asking patients about 
family history of glaucoma, 64 % reported discussing adherence to treatment, and only 35 % stated that they explain 
how to use eye drops, while most of respondents (87 %) regularly provide refill prescriptions for glaucoma medica-
tions. Sixty percent claimed that during their residency they had not acquired adequate knowledge and competence 
to allow them to take proper care of glaucoma patients. The main barriers reported were lack of time (43 %), lack of 
knowledge regarding treatment options and recommended follow-up (46 %), and not being familiar with glaucoma 
medications’ side effects (54 %).
Conclusions: There is a gap between PCPs’ perceptions of their role in glaucoma care and their report on actual 
performance in early detection and management of glaucoma. Further research is needed to develop and assess 
interventions that aim at closing this gap.
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Background
Primary open angle glaucoma (POAG), the most com-
mon type of glaucoma, is a leading cause of irrevers-
ible blindness, accounting for 2  % of visual impairment 
and 8  % of blindness globally [1]. In 2011, 2.71 million 
persons in the United States had POAG, with the highest 
estimated number among populations aged 70–79 years 
[2]. In the UK, the NHS recently reported more than 
one million glaucoma related visits per year [3]. In Israel, 
glaucoma affects approximately 10 % of persons aged 65 
or above, and it is the third most common cause of blind-
ness [4, 5].
Glaucoma is sometimes referred to as the “silent 
blinder” because of its asymptomatic nature until late in 
course. In developed countries, almost 70 % of cases are 
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not detected [6], and 39 % of patients with glaucoma pre-
sent with advanced disease in at least one eye [7]. Risk 
factors of family history, black race, advanced age and 
elevated intraocular pressure (IOP) are associated with 
increased risk for POAG [8]. Early diagnosis and treat-
ment of glaucoma has been found clinically beneficial and 
cost effective, as it significantly delays visual field deterio-
ration [9, 10]. Most patients receive IOP-lowering topi-
cal medications for the treatment of glaucoma and need 
lifelong treatment and regular follow-ups to improve out-
comes [11]. However, adherence to glaucoma pharmaco-
therapy, defined as the extent to which a patient follows 
a treatment plan as it was prescribed [12], is often poor, 
as more than 25 % of glaucoma patients do not take their 
prescribed medications regularly [13]. Among the key 
reasons for this are patients’ lack of faith in the necessity 
of treatment and the fear of using eye drops [14, 15].
Primary care physicians (PCPs) are well positioned to 
participate in the prevention and management of glau-
coma, by ensuring that at-risk patients are screened for the 
disease, and by providing educational information about 
the disease and its treatment. Patients perceive their PCPs 
as reliable and turn to them for advice and assistance on 
health-related issues in general and eye health in particular 
[16]. In a survey conducted in the USA by the National Eye 
Institute (NEI) almost all adults (96 %) responded that they 
would go for an eye checkup if their PCP recommended 
it [17]. Furthermore, the relationship between PCPs and 
their patients can influence patients’ health-related behav-
ior such as adherence to medical treatment [18]. Addition-
ally, good communication and collaboration between the 
PCP and the ophthalmologist in glaucoma care may assist 
in early detection of glaucoma medications’ systemic side 
effects, and in maintaining the continuity of visits to the 
ophthalmologist [19, 20].
In health care systems where the PCP is the patient’s 
case manager and provides monthly chronic prescrip-
tions for all medical treatments, including ophthalmic 
medications [21], the PCP can ascertain the use of glau-
coma medications as prescribed and detect barriers to 
adherence to glaucoma pharmacotherapy [22]. However, 
in our previous study, which explored factors associated 
with adherence to glaucoma pharmacotherapy among 
738 patients with long-standing glaucoma, we found 
that PCPs, in general, are not involved in glaucoma care. 
Although the majority of the participants in that study 
(90 %) described their relationship with the PCP as good, 
only 18  % reported that the PCP ever discussed with 
them the importance of adherence to glaucoma treat-
ment, and even fewer (16 %) claimed that their PCP had 
ever explained how to instil the eye drops [15].
In spite of the important role PCPs might have in glau-
coma care, to the best of our knowledge, no study to date 
has explored factors that influence the delivery of glau-
coma prevention and management by PCPs.
The current study aims to investigate PCPs’ attitudes 
towards their role in glaucoma care, self-reported perfor-
mance in glaucoma management, and perceived barriers 
towards their participation in glaucoma prevention and 
treatment.
Methods
Participants
The study population consisted of PCPs registered in the 
2011 computerized database of the Haifa and Western 
Galilee District of Clalit Health Services (CHS), Israel’s 
largest health maintenance organization (HMO), which 
has a well-established community care system and pro-
vides full medical coverage to over 50 % of Israel’s pop-
ulation, approximately 700,000 of whom reside in Haifa 
and its vicinity. All PCPs employed by Haifa and West-
ern Galilee district of CHS (n = 380) are entitled to four 
fully paid weekly hours of continuing medical educa-
tion (CME) activities funded by CHS. Physicians were 
approached during CME meetings in each of the five 
2011-CME program venues. Upon agreement to par-
ticipate in the survey, physicians were asked to complete 
an anonymous, structured, self-administered question-
naire and return it to the researchers by mail, fax or in 
person. The study was approved by the Clalit Health Ser-
vices’ Institutional Review Board, at the Meier Medical 
Centre (No. K 027/2011). Written informed consent was 
obtained from all participants.
Questionnaire
Based on a thorough literature review regarding the role 
of PCPs in glaucoma care [19, 20, 22–24], and poten-
tial barriers for the participation of PCPs in preventive 
care and risk factors management [25–27], a structured 
questionnaire was designed, consisting of the following 
sections:
  • Characteristics of the responding physicians This sec-
tion included personal data (i.e., age, gender, resi-
dency stage, medical school from which they gradu-
ated, number of years since MD graduation and 
glaucoma morbidity among the respondents and 
their first- degree relatives); and data on participants’ 
patient population (i.e., the number of patients aged 
40 or above, and the number of glaucoma patients on 
their lists).
  • Self-reported performance in glaucoma care Physi-
cians were asked to rate on a numerical scale how 
often they behave in practice in accordance with 
statements describing the assumed role of the 
PCP in glaucoma care, including: early detection 
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of glaucoma (1 item), management of glaucoma 
medical treatment (2 items) and adherence to 
treatment (2 items), and glaucoma care coordina-
tion and relationships with the ophthalmologist (3 
items). Similarly, physicians were asked to rate how 
often they refill chronic prescription for glaucoma 
treatment (recommended by the ophthalmologist). 
The following response scale was used for all self- 
reported performance items: 1- never, 2- rarely, 3- 
sometimes, 4- often, 5- usually, 6-always.
  • PCPs’ attitudes and perceptions regarding their role 
in glaucoma care Physicians were asked to rate to 
what extent they agree with each of the statements 
describing the assumed role of the PCP in glaucoma 
care using the following response scale: 1- not at all, 
2- to a very small extent, 3- to a small extent, 4- to 
a moderate extent, 5- to a large extent, 6- to a very 
large extent.
  • PCPs’ perceived barriers to participation in glaucoma 
care physicians were asked to rate on a numerical 
scale to what extent each of the following factors 
impedes their performance in glaucoma care: time, 
knowledge about glaucoma risk factors, knowledge 
regarding diagnostic evaluation, and knowledge 
regarding treatment of glaucoma and its adverse 
effects. Similarly, physicians were asked to rate to 
what extent, in their opinion, they had received 
adequate glaucoma-related education in medical 
school or during family medicine residency training. 
The following response scale was used for the above 
items: 1- not at all, 2- to a very small extent, 3- to a 
small extent, 4- to a moderate extent, 5- to a large 
extent, 6- to a very large extent.
The questionnaire was validated in the following man-
ner: a multidisciplinary team consisting of two board 
certified PCPs (OCC, KK), and an ophthalmologist spe-
cializing in glaucoma care (OG) compiled a list of ques-
tions according to study objectives. The wording of the 
questions was further pre-tested by administering the 
questionnaire to a group of five board certified PCPs to 
ensure that the questions were intelligible and answera-
ble. Physicians were debriefed after completing the ques-
tionnaire and the questionnaire was revised based on 
their comments.
Data analysis
All data analyses were performed using the SPSS version 
18 statistical program (SPSS INC, Chicago, IL, USA). 
Means and standard error deviations are reported for 
continuous variables. Pairwise comparison of means was 
based on a paired t test and comparison of percentages 
was based on χ2 test. Fisher’s exact test was used when 
cell frequencies were five or less. Correlations between 
categorical variables were examined using the Spearman’s 
rank correlation coefficient. Cronbach’s alpha was calcu-
lated to assess internal consistency of the items related 
to two domains: self-reported performance in glaucoma 
care (8 items); and PCP’s perception of their role in glau-
coma care (8 items). The high level of internal consist-
ency among items (Cronbach’s Alpha ≥0.8) enabled the 
formation of a new complex variable for each domain by 
calculating the mean score of the items of which it con-
sists. A significant difference was defined as alpha <0.05 
for all statistical tests.
Results
Between February and December 2011, 167 PCPs, out 
of the 180 physicians (93  %) enrolled in the CME pro-
gram, were invited to participate in the study. Of those 
invited, 82 (49 %) completed and returned the question-
naires. The respondents’ characteristics are presented in 
Table 1. Of the respondents included in the analyses, 19 
(23 %) were residents in family medicine during hospital 
rotations, and reported that they could not estimate the 
number of glaucoma patients they were presently treat-
ing, from among all of their patients.
Table 1 Characteristics of  study participants and  their 
patients (n = 82)
Characteristics
Age, years mean (SD) 43 (11), range 27–64
Gender, n (%)
 Men 31 (38)
 Women 51 (62)
Years since medical school graduation, mean (SD) 15 (11), range 2–40
Place of medical school graduation, n (%)
 Israel 46 (56)
 Former Soviet Union 16 (20)
 Europe (excluding the Soviet Union) 15 (18)
 Other 5 (6)
Glaucoma among participants (self report), n (%) 3 (4)
Glaucoma among family members, n (%) 10 (12)
Main place of work, n (%)
 Community clinic 63 (77)
 Hospital 19 (23)
Estimated number of patients > 40 years old, n (%)
 <500 28 (34)
 500≤ 35 (43)
 Don’t know 19 (23)
Estimated number of glaucoma patients, n (%)
 <20 34 (42)
 20≤ 29 (35)
 Don’t know 19 (23)
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Most of the PCPs who participated in this study 
(n = 71, 87 %) claimed that they often, usually, or always 
(i.e., answered 4, 5 or 6 on the numerical scale) provide 
monthly chronic prescriptions for glaucoma medications, 
and the majority of respondents (n = 76, 93 %) thought 
that the involvement of the PCP in glaucoma care can 
improve patients’ adherence to treatment.
Table  2 presents the rates of respondents who agree 
with statements describing the assumed role of the PCP 
in glaucoma care, side by side with the rates of respond-
ents who report that they behave in practice according to 
each of these role descriptions.
Participants’ mean score for the extent of their agree-
ment with each of the role descriptions ranged between 
4.6  ±  1.2 (for “Explaining the proper use of eye drops 
to glaucoma patients”), and 5.5  ±  0.8 (for “Identifying 
patients at high risk of glaucoma”).
Participants’ mean score for the frequency of their 
performance according to each of the role descriptions 
ranged between 2.7  ±  1.5 (for “Asking older patients 
about family history of glaucoma”), and 4.7  ±  1.4 (for 
“Encouraging glaucoma patients to undergo periodic 
ophthalmologic follow-up examination”).
The mean score for the complex variable self-reported 
performance in glaucoma care (Cronbach’s alpha =  0.9) 
was significantly lower than the mean score for the com-
plex variable PCP’s perception of their role in glaucoma 
care (Cronbach’s alpha  =  0.8), (3.8  ±  1.1; 5.2  ±  0.6, 
respectively, p < 0.0001). However, a positive correlation 
was found between these two complex variables (r = 0.5, 
p < 0.001).
In addition, positive correlations were found between 
physicians’ age and number of years since MD graduation 
and self-reported performance in glaucoma care (r = 0.31, 
p = 0.007; r = 0.33, p = 0.005, respectively).
The barriers reported by the respondents for partici-
pating in glaucoma care are specified in Table  3. Nega-
tive correlations were found between physicians’ age and 
number of years since MD graduation, and the extent 
to which lack of knowledge regarding glaucoma adverse 
effects was perceived as a barrier to participate in glau-
coma care (r = −0.29, p = 0.015; r = −0.24, p = 0.045, 
respectively). Similarly, a negative correlation was found 
between the number of years since MD graduation and 
the extent to which lack of knowledge regarding glaucoma 
treatment and follow-up was perceived as a barrier to 
participate in glaucoma care (r = −0.24, p = 0.05).
In addition, most of the respondents (n  =  57, 70  %) 
claimed that they had not been provided with adequate 
glaucoma-related knowledge during medical school, 
and more than half of the respondents (n  =  49, 60  %) 
claimed that they had not acquired adequate glaucoma 
care-related knowledge and skills during their residency 
training.
Table 2 Primary care physicians’ self-reported performance in  glaucoma care and  agreement with  role descriptions 
(n = 82)
a Answered 4 or above on a 1–6 numerical scale (1-never; 6-always)
b Answered 4 or above on a 1–6 numerical scale (1-not at all; 6-to a very large extent)
1 Statement describing PCP’s behavior in practice
2 Statement describing the assumed role of the PCP in glaucoma care
Domain Role description Agree with the role 
description
Behave in practice 
accordingly
n (%)b Mean (SD) n (%)a Mean (SD)
Early detection Asking older patients about family history of glaucoma and 
referring them to complete ophthalmologic examination1/iden-
tifying patients at high risk of glaucoma and referring them to 
complete ophthalmologic examination2
81 (99)2 5.5 (0.8)2 24 (30)1 2.7 (1.5)1
Management of  
medical treatment
Explaining the proper use of eye drops to glaucoma patients 69 (85) 4.6 (1.2) 28 (35) 2.8 (1.4)
Asking glaucoma patients about treatment’s adverse effects 71 (88) 5.1 (1.2) 37 (46) 3.3 (1.5)
Promoting adherence to 
treatment and follow up
Discussing the importance of adherence to treatment with 
glaucoma patients
75 (93) 5.2 (1.0) 52 (64) 4.0 (1.6)
Encouraging glaucoma patients to have regular ophthalmologic 
follow-up examination
78 (99) 5.4 (0.7) 64 (81) 4.7 (1.4)
Coordination of eye care Maintaining good relations with ophthalmologists working in the 
community clinics
74 (91) 5.1 (1.0) 45 (56) 3.6 (1.8)
Informing the ophthalmologist on treatment’s adverse effects or 
contraindications to treatment
74 (93) 5.2 (1.0) 42 (53) 3.6 (1.5)
Receiving and reading follow-up letters from the ophthalmolo-
gists concerning glaucoma patients
76 (94) 5.3 (1.0) 57 (70) 4.3 (1.5)
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Discussion
The reported performance of PCPs who participated in 
this study varies greatly across the different domains of 
glaucoma care and is associated with physicians’ attitudes 
towards their role in the management of the disease. How-
ever, there is a significant gap between participants’ level 
of agreement with each of the role descriptions and the 
frequency of reported performance, which may imply 
that physicians in this study perceive their performance in 
glaucoma care as less-than-desirable. Most respondents 
reported that they do not usually ask patients about fam-
ily history of glaucoma, although most of them agree that 
it is the role of the PCP to identify patients at high risk for 
glaucoma. Furthermore, although the majority of the PCPs 
provide refill authorizations for chronic, ophthalmolo-
gist-prescribed glaucoma prescriptions, many of them 
reported that they rarely explain how to use the drops 
to their patients, or inquire about glaucoma treatment’s 
adverse effects. On the other hand, physicians in this study 
reported being highly involved in promoting adherence to 
treatment and coordinating eye care. These behaviors are 
not glaucoma specific, and demand the application of the 
more “generic” skills of the PCP, which might make them 
self-evident and easier to perform. Indeed, study partici-
pants stated that glaucoma-related knowledge gaps, espe-
cially in relation to treatment’s adverse effects are major 
barriers to their performance in glaucoma care.
Other factors that were found to be associated in this 
study with physicians’ self-reported performance in glau-
coma care were physicians’ age and their years of medi-
cal experience. One possible explanation is that older and 
more experienced physicians, (at least those who partici-
pate in CME programs), have managed to overcome glau-
coma-related knowledge gaps that were not adequately 
attended to, according to study participants, during 
medical school or residency training. More experienced 
physicians might also deal better with time constraints, 
a topic which was also rated by many participants as a 
major barrier to their performance in glaucoma care.
This study is the first one, to our knowledge, to exam-
ine PCPs’ perception of their role in glaucoma care and 
their self-reported participation in the management of the 
disease. Our results conform to those of a recently pub-
lished meta-ethnographic synthesis of qualitative research 
by Rubio-Valera et al., which found that factors affecting 
the performance of PCPs in the implementation of pri-
mary prevention and health promotion activities in adults 
include experience, skills and knowledge, as well as lack 
of time and the low importance ascribed to the subject 
matter in the medical school curriculum [28]. In addition, 
data from the 2012 American Academy of Family Physi-
cians (AAFP) CME Needs Assessment survey also resem-
bles the results of our current study by indicating that 
family physicians have knowledge gaps that may impede 
their optimal management of patients with glaucoma [29].
Our study has several limitations. The study was con-
fined to a sample of PCPs attending a CME program, 
rather than all practicing PCPs. Hence, it is possible that 
the sample differed systematically from physicians who 
do not participate in a CME program. In addition, about 
a quarter of the sample (23 %, n = 19) were residents in 
family medicine. This and the relatively small sample size 
limit the generalizability of the findings. However, all 
the residents that participated in this study had already 
completed a 15-months rotation in community clinics 
working as full time PCPs. They were approached during 
in- hospital internal medicine or pediatric rotations, at 
the end of which they returned to the primary care clin-
ics. Their glaucoma related educational needs and role 
perception could, but don’t necessarily reflect those of 
other young PCPs.
Physicians who agreed to participate in this study might 
have greater interest and more positive attitudes towards 
their role in glaucoma care compared to those who declined.
The high rates of participants’ agreement with the 
literature-based descriptions of their role in glaucoma 
care could be, at least in part, due to social desirability, 
and hence, possibly bias the study results. On the other 
hand, the application of this perspective to participants’ 
self-reported performance suggests that in reality, PCPs’ 
performance in glaucoma care is even more limited than 
reported in this study. Possible ways of encouraging PCPs 
to be more involved in glaucoma care are financial incen-
tives and the use of reminders in computerized medical 
records, but the effectiveness of these tools is yet to be 
proven [28]. In addition, physicians can improve their 
care of glaucoma patients by engaging in continuing 
medical education that provides practical, current, evi-
dence-based guidelines and recommendations related to 
glaucoma prevention and management [30].
Conclusions
The results of the current study suggest that PCPs are 
highly aware of their role in glaucoma care; however, they 
Table 3 Primary care physicians’ perceived barriers to par-
ticipation in glaucoma care (n = 82)
a Answered 4 and above on a 1–6 numerical scale (1-not at all; 6-to a very large 
extent)
Factors n (%)a Mean (SD)
Lack of time 36 (45) 3.1 (1.6)
Lack of knowledge regarding:
 Glaucoma risk factors
 Diagnostic evaluation
 Treatment options and recommended follow-up
 Glaucoma medications’ adverse effects
27 (33)
25 (30)
40 (48)
43 (53)
3.0 (1.5)
2.7 (1.6)
3.6 (1.3)
3.6 (1.1)
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often do not pursue this role, due to lack of knowledge 
and time.
Further research is needed to develop and assess 
interventions that address PCPs perceived barriers to 
participating in glaucoma care. Specifically, additional 
studies are needed to examine whether the participation 
of PCPs in a high-quality, outcome- based CME designed 
to address the educational needs described in this study 
improves their performance in glaucoma care.
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